| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.09B | 59.31B | 53.13B | 60.68B | 56.59B | 59.33B |
| Gross Profit | 12.49B | 13.26B | 11.99B | 12.74B | 12.25B | 12.32B |
| EBITDA | 8.34B | 8.88B | 7.78B | 8.84B | 8.43B | 8.75B |
| Net Income | 6.09B | 6.33B | 5.27B | 5.96B | 5.64B | 5.91B |
Balance Sheet | ||||||
| Total Assets | 86.29B | 101.19B | 95.63B | 96.86B | 91.74B | 92.29B |
| Cash, Cash Equivalents and Short-Term Investments | 21.68B | 46.87B | 42.13B | 39.03B | 38.08B | 37.76B |
| Total Debt | 171.64M | 214.58M | 255.99M | 308.30M | 397.57M | 443.32M |
| Total Liabilities | 14.59B | 17.17B | 13.84B | 18.29B | 15.70B | 18.97B |
| Stockholders Equity | 71.71B | 84.02B | 81.79B | 78.57B | 76.04B | 73.32B |
Cash Flow | ||||||
| Free Cash Flow | -4.52B | 6.87B | 6.04B | 3.72B | 3.33B | 10.20B |
| Operating Cash Flow | 363.20M | 9.87B | 7.11B | 4.51B | 3.99B | 10.87B |
| Investing Cash Flow | -3.73B | -1.96B | 32.76B | -2.25B | 997.70M | -10.66B |
| Financing Cash Flow | -17.44B | -3.13B | -3.55B | -3.23B | -3.22B | -3.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥6.12T | 12.01 | ― | 4.06% | 0.40% | 8.40% | |
73 Outperform | ¥314.25B | 12.67 | ― | 2.99% | 0.31% | -11.04% | |
70 Outperform | ¥91.35B | 15.03 | ― | 4.79% | 1.68% | 18.85% | |
70 Outperform | ¥182.93B | 6.43 | 9.45% | 2.86% | 10.49% | -5.19% | |
67 Neutral | ¥1.21T | 13.34 | 9.16% | 3.98% | -2.72% | 29.43% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | ¥17.35B | 0.51 | ― | 5.40% | -2.22% | 18.80% |